HSP27 but not HSP70 has a potent protective effect against α-synuclein-induced cell death in mammalian neuronal cells

Journal of Neurochemistry

Volumn 88, Issue 6, 2004, Pages 1439-1448

  Zourlidou, Alexandra ^a   Payne Smith, Martin D ^a   Latchman, David S ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apoptosis; Dopamine; Heat shock proteins; Ischaemia; Parkinson's disease; synuclein

Indexed keywords

ALPHA SYNUCLEIN; CASPASE INHIBITOR; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; MUTANT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; GENE MUTATION; MAMMAL; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALIA; MAMMALIA;

EID: 1642356755     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02273.x     Document Type: Article

References (47)

1. Akbar M. T., Lundberg A. M., Liu K., Vidyadaran S., Wells K. E., Dolatshad H., Wynn S., Wells D. J., Latchman D. S. and De Belleroche J. S. (2003) The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death. J. Biol. Chem. 278, 19956-19965.
2. Alves da Costa C., Ancolio K. and Checler F. (2000) Wild-type but not Parkinson's disease-related ala-53 → Thr mutant α-synuclein protects neuronal cells from apoptotic. J. Biol. Chem. 275, 24065-24069.
3. Angelidis C. E., Lazaridis I. and Pagoulatos G. N. (1991) Constitutive expression of heat-shock protein 70 in mammalian cells confers thermoresistance. Eur. J. Biochem. 199, 35-39.
4. Auluck P. K., Chan H. Y., Trojanowski J. Q., Lee V. M. and Bonini N. M. (2002) Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295, 865-868.
5. Bansal G. S., Norton P. M. and Latchman D. S. (1991) The 90-kDa heat shock protein protects mammalian cells from thermal stress but not from viral infection. Exp. Cell Res. 195, 303-306.
6. Benjamin I. J. and McMillan D. R. (1998) Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ. Res. 83, 117-132.
7. Benn S. C., Perrelet D., Kato A. C., Scholz J., Decosterd I., Mannion R. J., Bakowska J. C. and Woolf C. J. (2002) HSP27 upregulation and phosphorylation is required for injured sensory and motor neuron survival. Neuron 36, 45-56.
8. Brar B. K., Stephanou A., Wagstaff M. J., Coffin R. S., Marber M. S., Engelmann G. and Latchman D. S. (1999) Heat shock proteins delivered with a virus vector can protect cardiac cells against apoptosis as well as against thermal or hypoxic stress. J. Mol. Cell Cardiol. 31, 135-146.
9. Bruey J. M., Ducasse C., Bonniaud P. et al. (2000) HSP27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell Biol. 2, 645-652.
10. Concannon C. G., Gorman A. M. and Samali A. (2003) On the role of HSP27 in regulating apoptosis. Apoptosis 8, 61-70.
11. Cummings C. J., Sun Y., Opal P., Antalffy B., Mestril R., Orr H. T., Dillmann W. H. and Zoghbi H. Y. (2001) Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 10, 1511-1518.
12. Esumi K., Nishida M., Shaw D., Smith T. W. and Marsh J. D. (1991) NADH measurements in adult rat myocytes during simulated ischernia. Am. J. Physiol. 260, H1743-H1752.
13. Feany M. B. and Bender W. W. (2000) A Drosophila model of Parkinson's disease. Nature 404, 394-398.
14. Fernandez-Funez P., Nino-Rosales M. L., de Gouyon B. et al. (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408, 101-106.
15. Glover J. R. and Lindquist S. (1998) HSP104, HSP70, and HSP40: a novel chaperone system that rescues previously aggregated proteins. Cell 94, 73-82.
16. Goedert M. (1997) Familial Parkinson's disease. The awakening of α-synuclein. Nature 388, 232-233.
17. Hartl F. U. and Hayer-Hartl M. (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295, 1852-1858.
18. Howard M. K., Burke L. C., Mailhos C., Pizzey A., Gilbert C. S., Lawson W. D., Collins M. K. L., Thomas N. S. B. and Latchman D. S. (1993) Cell cycle arrest of proliferating neuronal cells by serum deprivation can result in either apoptosis or differentiation. J. Neurochem. 60, 1783-1791.
19. Howard M. K., Kershaw T., Gibb B. et al. (1998) High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. Gene Ther 5, 1137-1147.
20. Iwata A., Maruyama M., Kanazawa I. and Nukina N. (2001) α-Synuclein affects the MAPK pathway and accelerates cell death. J. Biol. Chem. 276, 45320-45329.
21. Jakob U. and Buchner J. (1994) Assisting spontaneity: the role of HSP90 and small HSPs as molecular chaperones. Trends Biochem. Sci. 19, 205-211.
22. Kalwy S. A., Akbar M. T., Coffin R. S., de Belleroche J. and Latchman D. S. (2003) Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainic-acid-induced cell loss. Brain Res. Mol. Brain Res. 111, 91-103.
23. Kazemi-Esfarjani P. and Benzer S. (2000) Genetic suppression of polyglutamine toxicity in Drosophila. Science 287, 1837-1840.
24. Kiang J. G. and Tsokos G. C. (1998) Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol. Ther. 80, 183-201.
25. Ko L.-W., Mehta N. D., Farrer M., Easson C., Hussey J., Yen S., Hardy J. and Yen S.-H. C. (2000) Sensitization of neuronal cells to oxidative stress with mutated human α-synuclein. J. Neurochem. 75, 2546-2554.
26. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J. T., Schols L. and Riess O. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108.
27. Lang A. E. and Lozano A. M. (1998) Parkinson's disease. First of two parts. N. Engl. J. Med. 339, 1044-1053.
28. Lee M. H., Hyun D.-H., Halliwell B. and Jenner P. (2001) Effect of the overexpression of wild-type or mutant α-synuclein on cell susceptibility to insult. J. Neurochem. 76, 998-1009.
29. Li J., Uversky V. N. and Fink A. L. (2001) Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human α-synuclein. Biochemistry 40, 11604-11613.
30. Maroteaux L., Campanelli J. T. and Scheller R. H. (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815.
31. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A. and Mucke L. (2000) Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269.
32. McLean P. J., Kawamata H., Shariff S., Hewett J., Sharma N., Ueda K., Breakefield X. O. and Hyman B. T. (2002) TorsinA and heat shock proteins act as molecular chaperones: suppression of α-synuclein aggregation. J. Neurochem. 83, 846-854.
33. Mehlen P., Kretz-Remy C., Preville X. and Arrigo A. P. (1996) Human HSP27, Drosophila HSP27 and human B-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNF-induced cell death. EMBO J. 15, 2695-2706.
34. Muchowski P. J. (2002) Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones? Neuron 35, 9-12.
35. Narhi L., Wood S. J., Steavenson S. et al. (1999) Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274, 9843-9846.
36. Parcellier A., Gurbuxani S., Schmitt E., Solary E. and Garrido C. (2003) Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem. Biophys. Res. Commun. 304, 505-512.
37. Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
38. Pratt W. B. and Welsh M. J. (1994) Chaperone functions of the heat shock proteins associated with steroid receptors. Semin. Cell Biol. 2, 83-93.
39. Sherman M. Y. and Goldberg A. L. (2001) Cellular defences against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29, 15-32.
40. Tabrizi S. J., Orth M., Wilkinson J. M., Taanman J.-W., Warner T. T., Cooper J. M. and Schapira A. H. V. (2000) Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity. Hum. Mol. Genet. 9, 2683-2689.
41. Tatton W. G., Chalmers-Redman R., Brown D. and Tatton N. (2003) Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann. Neurol. 53, 61-70.
42. Wagstaff M. J., Collaco-Moraes Y., Smith J., de Belleroche J. S., Coffin R. S. and Latchman D. S. (1999) Protection of neuronal cells from apoptosis by HSP27 delivered with a herpes simplex virus-based vector. J. Biol. Chem. 274, 5061-5069.
43. Warrick J. M., Chan H. Y., Gray-Board G. L., Chai Y., Paulson H. L. and Bonini N. M. (1999) Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet. 23, 425-428.
44. Wood J. N., Bevan S. J., Coote P., Darn P. M., Hogan P., Latchman D. S., Morrison C., Rougon G., Theveniau M. and Wheatley S. C. (1990) Novel cell lines display properties of nociceptive sensory neurons. Proc. R. Soc. Lond. Series B. Biol. Sci. 241, 187-194.
45. Wyttenbach A., Sauvageot O., Carmichael J., Diaz-Latoud C., Arrigo A. P. and Rubinsztein D. C. (2002) Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum. Mol. Genet. 11, 1137-1151.
46. Zhou W., Hurlbert M. S., Schaack J., Prasad K. N. and Freed C. R. (2000) Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res. 866, 33-43.
47. Zourlidou A., Payne Smith M. D. and Latchman D. S. (2003) Modulation of cell death by α-synuclein is stimulus-dependent in mammalian cells. Neurosci. Lett. 340, 234-238.